Skip to main content
. 2023 Jan 30;15(3):846. doi: 10.3390/cancers15030846

Figure 3.

Figure 3

Disease-free survival (DFS) for total cases treated with SBRT and repeated cases treated with SBRT. (a) DFS for total cases (median DFS, 17 months; 95% CI, 14–23 months). (b) DFS for repeated cases (median DFS from first SBRT, 13 months; 95% CI, 9–17 months).